{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["15(2)"],"submitter":["Karve S"],"funding":["Eli Lilly and Company"],"pubmed_abstract":["Purpose
To assess real-world treatment patterns, health care utilization, costs, and survival among Medicare enrollees with locally advanced/unresectable or metastatic gastric cancer receiving standard first-line chemotherapy.Materials and methods
This was a retrospective analysis of the Surveillance, Epidemiology, and End Results-Medicare linked database (2000~2009). The inclusion criteria were as follows: (1) first diagnosed with locally advanced/unresectable or metastatic gastric cancer between July 1, 2000 and December 31, 2007 (first diagnosis defined the index date); (2) ≥65 years of age at index; (3) continuously enrolled in Medicare Part A and B from 6 months before index through the end of follow-up, defined by death or the database end date (December 31, 2009), wh"],"journal":["Journal of gastric cancer"],"pagination":["87-104"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4496446"],"repository":["biostudies-literature"],"pubmed_title":["Treatment Patterns, Costs, and Survival among Medicare-Enrolled Elderly Patients Diagnosed with Advanced Stage Gastric Cancer: Analysis of a Linked Population-Based Cancer Registry and Administrative Claims Database."],"pmcid":["PMC4496446"],"pubmed_authors":["Lorenzo M","Liepa AM","Kaye JA","Hess LM","Karve S","Calingaert B"],"additional_accession":[]},"is_claimable":false,"name":"Treatment Patterns, Costs, and Survival among Medicare-Enrolled Elderly Patients Diagnosed with Advanced Stage Gastric Cancer: Analysis of a Linked Population-Based Cancer Registry and Administrative Claims Database.","description":"Purpose
To assess real-world treatment patterns, health care utilization, costs, and survival among Medicare enrollees with locally advanced/unresectable or metastatic gastric cancer receiving standard first-line chemotherapy.Materials and methods
This was a retrospective analysis of the Surveillance, Epidemiology, and End Results-Medicare linked database (2000~2009). The inclusion criteria were as follows: (1) first diagnosed with locally advanced/unresectable or metastatic gastric cancer between July 1, 2000 and December 31, 2007 (first diagnosis defined the index date); (2) ≥65 years of age at index; (3) continuously enrolled in Medicare Part A and B from 6 months before index through the end of follow-up, defined by death or the database end date (December 31, 2009), wh","dates":{"release":"2015-01-01T00:00:00Z","publication":"2015 Jun","modification":"2026-04-30T07:29:36.852Z","creation":"2019-03-27T01:54:50Z"},"accession":"S-EPMC4496446","cross_references":{"pubmed":["26161282"],"doi":["10.5230/jgc.2015.15.2.87"]}}